You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

MARINOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Marinol, and when can generic versions of Marinol launch?

Marinol is a drug marketed by Alkem Labs Ltd and is included in one NDA.

The generic ingredient in MARINOL is dronabinol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dronabinol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Marinol

A generic version of MARINOL was approved as dronabinol by ASCENT PHARMS INC on February 7th, 2020.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MARINOL?
  • What are the global sales for MARINOL?
  • What is Average Wholesale Price for MARINOL?
Summary for MARINOL
Drug patent expirations by year for MARINOL
Drug Prices for MARINOL

See drug prices for MARINOL

Recent Clinical Trials for MARINOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
JHSPH Center for Clinical TrialsPhase 2
Ralph H. Johnson VA Medical CenterPhase 2
Yale UniversityPhase 1

See all MARINOL clinical trials

Pharmacology for MARINOL
Drug ClassCannabinoid

US Patents and Regulatory Information for MARINOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MARINOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 ⤷  Sign Up ⤷  Sign Up
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.